LEPR and breast carcinoma: The prognostic evaluation of the LEP and LEPR genetic markers in breast carcinoma indicated that LEP (-2548) A allele is associated with a larger tumor size at diagnosis and a shorter disease-free survival, and that the LEPR 223R allele is associated with shorter overall survival, and therefore with a poor prognosis in breast carcinoma.